The aim of this study was to identify and investigate key genes involved in PCa progression and CRPC evolution toward AR-dependent (AR+) or AR-indifferent (AR−) subtypes in order to derive candidate markers with functional driver roles useful in PCa patients’ clinical management. This evidence concerns the gene AR and posterior cortical atrophy.